Position in SCYX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,977,173
New position
Shares Held
7,608,695
first reported quarter
Ownership
9.58%
of shares outstanding
% of Portfolio
2.79%
of 13F equity value
Holder Rank
#1
of 44 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Squadron Capital Management LLC holds $7,826,423 across 2 Drug Manufacturers - Specialty & Generic names. SCYX ranks #1 (89.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SCYX |
Scynexis Inc
This page
|
7,608,695 | $6,977,173 | |
| 2 | TXMD |
TherapeuticsMD, Inc.
|
420,421 | $849,250 |
All Filings in SCYX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,977,173 | 7,608,695 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||